Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Breast Cancer
•
Radiation Oncology
Would you omit post-lumpectomy radiotherapy for high clinical risk, but low molecular risk DCIS?
The patient had a high-grade DCIS with necrosis, but a 0.9 DCSionRT score
Answer from: Radiation Oncologist at Community Practice
For now, I have been only omitting/discussing omission if both, clinical path and molecular test are concordant.
Sign In
or
Register
to read more
21306
Related Questions
In what circumstances would you offer axillary re-irradiation after salvage axillary dissection?
Given the final publication of NSABP B-51, for which patients meeting trial eligibility would you still recommend regional nodal irradiation?
Would you consider RNI alone without CW for an isolated nodal recurrence after treatment with mastectomy and SNB for an early-stage breast cancer with no prior RT?
Given the new ASCO guidelines on SNB in early stage breast cancer, how does the omission of SNB in patients aged 50-70 impact your adjuvant radiation recommendations?
How would you treat a schwannoma of the breast with a positive margin that is not amenable to re-excision?
When using surface image-guidance for breast radiation, how do you accommodate for changes in anatomy?
How do you optimally set a patient up for breast radiation therapy if you don't have access to a breast board or wing board?
Would you consider omitting adjuvant radiation in a very elderly patient with a small triple negative breast cancer?
What are your top takeaways in Medical Oncology from SABCS 2025?
Is there any increased risk with adjuvant breast radiation for a patient with muscular dystrophy?